WHY LATEST EBOLA STRAIN HAS NO APPROVED VACCINE — AFRICA CDC

Why There’s No Approved Vaccine for the Ebola Type Behind the Latest Outbreak

Many people know that Ebola vaccines exist. So why is there still no approved vaccine for the virus behind the latest outbreak?

Africa Centres for Disease Control and Prevention (Africa CDC) says the outbreak involves Bundibugyo virus, a type of Ebola for which no vaccine has been specifically approved.

The explanation is that Ebola disease can be caused by different, related viruses. A vaccine developed for one type cannot automatically be assumed to protect people against another.

The existing Ervebo vaccine is approved against Ebola virus, previously known as Zaire ebolavirus. Scientists are still studying whether it can also protect against Bundibugyo. Africa CDC says the available evidence has not yet established its effectiveness against this virus.

Why has developing a vaccine taken so long?

Africa CDC has pointed to longstanding gaps in global health research funding. Diseases affecting lower-income countries often receive too little sustained investment until an outbreak creates an emergency.

Developing a vaccine also requires careful testing. Researchers must establish that it is safe and provides protection against the specific virus before it can receive approval for that use.

Work is underway on vaccines designed for Bundibugyo, alongside studies assessing whether existing vaccines could offer protection.

What can be done while research continues?

The absence of an approved vaccine does not mean the outbreak cannot be controlled. Africa CDC stresses the importance of identifying cases quickly, isolating infected patients, tracing contacts, protecting health workers and ensuring safe burials.

Early medical care also matters. Supportive treatment, including replacing lost fluids and managing complications, can improve a patient’s chances of survival.

For affected communities, the priority remains getting reliable information and seeking medical help promptly. Vaccine research is essential, but strong healthcare services and a rapid response remain crucial to saving lives.